Currrent status and research strategies in tuberculosis drug development

Lynn G. Dover, Geoffrey Coxon

Research output: Contribution to journalLiterature review

87 Citations (Scopus)

Abstract

In this Miniperspective we broadly cover the recent developments and strategies that are being adopted globally in the battle to urgently discover and develop new drugs to treat tuberculosis (TB). It highlights the impact and outcomes of recent nongovernment organizations (NGO) and academic research consortia that have made a significant impact in recent years in the field, providing the reader with an insight into the overall status of TB drug discovery and development while illustrating the current strategies and directions that are currently being adopted to find new drugs to control the disease.
LanguageEnglish
Pages6157–6165
Number of pages9
JournalJournal of Medicinal Chemistry
Volume54
Issue number18
Early online date8 Aug 2011
DOIs
Publication statusPublished - 2011

Fingerprint

Tuberculosis
Drug and Narcotic Control
Drug Discovery
Research
Pharmaceutical Preparations
Organizations
Direction compound

Keywords

  • drug discovery
  • drug development
  • tuberculosis
  • disease control

Cite this

@article{6c09a5b5fde146a88964b7bfd32726e3,
title = "Currrent status and research strategies in tuberculosis drug development",
abstract = "In this Miniperspective we broadly cover the recent developments and strategies that are being adopted globally in the battle to urgently discover and develop new drugs to treat tuberculosis (TB). It highlights the impact and outcomes of recent nongovernment organizations (NGO) and academic research consortia that have made a significant impact in recent years in the field, providing the reader with an insight into the overall status of TB drug discovery and development while illustrating the current strategies and directions that are currently being adopted to find new drugs to control the disease.",
keywords = "drug discovery, drug development, tuberculosis, disease control",
author = "Dover, {Lynn G.} and Geoffrey Coxon",
year = "2011",
doi = "10.1021/jm200305q",
language = "English",
volume = "54",
pages = "6157–6165",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "18",

}

Currrent status and research strategies in tuberculosis drug development. / Dover, Lynn G.; Coxon, Geoffrey.

In: Journal of Medicinal Chemistry, Vol. 54, No. 18, 2011, p. 6157–6165.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - Currrent status and research strategies in tuberculosis drug development

AU - Dover, Lynn G.

AU - Coxon, Geoffrey

PY - 2011

Y1 - 2011

N2 - In this Miniperspective we broadly cover the recent developments and strategies that are being adopted globally in the battle to urgently discover and develop new drugs to treat tuberculosis (TB). It highlights the impact and outcomes of recent nongovernment organizations (NGO) and academic research consortia that have made a significant impact in recent years in the field, providing the reader with an insight into the overall status of TB drug discovery and development while illustrating the current strategies and directions that are currently being adopted to find new drugs to control the disease.

AB - In this Miniperspective we broadly cover the recent developments and strategies that are being adopted globally in the battle to urgently discover and develop new drugs to treat tuberculosis (TB). It highlights the impact and outcomes of recent nongovernment organizations (NGO) and academic research consortia that have made a significant impact in recent years in the field, providing the reader with an insight into the overall status of TB drug discovery and development while illustrating the current strategies and directions that are currently being adopted to find new drugs to control the disease.

KW - drug discovery

KW - drug development

KW - tuberculosis

KW - disease control

UR - http://www.scopus.com/inward/record.url?scp=80052814263&partnerID=8YFLogxK

U2 - 10.1021/jm200305q

DO - 10.1021/jm200305q

M3 - Literature review

VL - 54

SP - 6157

EP - 6165

JO - Journal of Medicinal Chemistry

T2 - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 18

ER -